Highlighted Market Movers
PTLA +46% FDA approves BEVYXXA
AVEO +71% Announces Positive CHMP Opinion for Tivozanib as a Treatment of Advanced Renal Cell Carcinoma
BBRY -12% Announced Earnings, Beats on EPS, Misses on Revenue
BBBY -12% Announced Earnings, Misses on EPS and Revenue
The world's largest biotech fund, the iShares Nasdaq Biotech ETF, has had a quiet couple of months. For the last four months, the fund has been consolidating in a tight range between about 285.00 and 303.00. That changed abruptly this week, with prices surging out of that range to hit a high above 320.00.